Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 403-830-5 | CAS number: 89331-94-2 B 290; BK 400; CK 34; DIBUTYL-N-102; DX-20; FAT NR. 40391/A; FLUORAN BLACK BD 869; FLUORAN SCHWARZ BD 869; NOIR FLUORANE BD 869; ODB-2; PSD-290; SENOR-2; TG-31; TH-108; WINCON-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 June to 28 July 1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study undertaken at GLP accredited laboratory to internationally accepted guidelines.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- ODB-2
- IUPAC Name:
- ODB-2
- Reference substance name:
- 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one
- EC Number:
- 403-830-5
- EC Name:
- 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one
- Cas Number:
- 89331-94-2
- Molecular formula:
- C35 H36 N2 O3
- IUPAC Name:
- 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)-3H-spiro[2-benzofuran-1,9'-xanthen]-3-one
- Details on test material:
- - Name of test material (as cited in study report): ODB-2
- Substance type: Colour precursor for heat sensitive record sheets
- Physical state: White or light coloured powder.
- Analytical purity: 99% min.
- Impurities (identity and concentrations): no data
- Purity test date: no data
- Lot/batch No.: 61-24101
- Expiration date of the lot/batch: no data
- Storage condition of test material: In the dark at room temperature
- Other: date received Lot 61-24101 26 January 1988
Constituent 1
Constituent 2
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Chinese hamster ovary (CHO) cells, strain K1-BH4
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: no data
- Periodically checked for karyotype stability: no data
- Periodically "cleansed" against high spontaneous background: no data - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- 4, 20 and 40 µg / ml
- Vehicle / solvent:
- - Solvent used: DMSO;
- Justification for choice of solvent: commonly used as a vehicle.
Controlsopen allclose all
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in suspension;
DURATION
- Preincubation period: 24 hours
- Exposure duration: 4 hours
- Expression time (cells in growth medium): 17 hours
- Selection time (if incubation with a selection agent): 21 hours
- Fixation time (start of exposure up to fixation or harvest of cells): 49 hours
SPINDLE INHIBITOR (cytogenetic assays): Colchicine
NUMBER OF REPLICATIONS: 1
NUMBER OF CELLS EVALUATED: no data
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index;
OTHER EXAMINATIONS:
Chromosome aberrations
Gaps / Breaks; Chromatid and isochromatid
Chromatid exchanges
Dicentric chromosomes
Acentric chromosome fragments
Chromosome rings
Complex rearrangements. - Evaluation criteria:
- Chromosomes are examined in these metaphase cells for the presence of the following aberrations:
Gaps, breaks, Chromatid and isochromatid
Chromatid exchanges
Dicentric chromosomes
Acentric chromosome fragments
Chromosome rings
Complex rearrangements.
A gap is defined as an achromatic region (occurring in one or both chromatids) which is smaller than the width of a single chromatid. The
separated regions are still aligned. A break is defined as an achromatic region, occurring in one or both chromatids, that is greater than the width of a single chromatid. The accompanying fragment is usually displaced from the rest of the chromosome.
Results and discussion
Test results
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Preliminary Toxicity Test
A 50 ml culture of CHO cells was harvested as follows: The supernatant medium was removed and the cells washed in 0.9% sterile
saline; 20 ml of 0.25% trypsin was then added for 30 seconds. The trypsin solution was removed and the flask incubated at 37°C for 10 minutes. The cells were then resuspended in 20 ml Hams F12 + 5% FCS and diluted to give 8E+04 cells/mI. Aliquots (5 ml) of cells were added to Nunc 25 cm2 tissue culture flasks and the cultures incubated at 37°C in a humid atmosphere containing 5% carbon dioxide.
After approximately 24 hours 1.25 µl of S-9 mix was added to one set of cultures followed by 62.5 µl of various dilutions of the test compound and of the solvent. To the second set of cultures (i.e. without S-9 mix) 50 µl of the dilutions of test compound and of the solvent were added. Final concentrations of test compound in both sets were 0.6, 1.3, 2.5, 5, 10, 20 and 40 µg/ml with single flasks for each concentration and duplicate flasks for the solvent control. The cultures without S-9 mix were incubated in the presence of the test compound for 21 hours.
Four hours after the addition of the test compound to those cultures treated with S-9 mix, the medium containing the S-9 mix and test
compound was carefully removed and replaced with fresh Hams F12 + 5% FCS. The cultures were returned to the incubator for a further 17 hours.
Metaphase analysis
After approximately 24 hours incubation 1.25 ml of S-9 mix was added to one set of cultures followed by 62.5 µl a1iquots of various dilutions of the test compound giving final concentrations of 4, 20 and 40 µg/ml. Two cultures were treated at each dose level. Four cultures were treated with 62.5 µl aliquots of the solvent control, DMS0, and two with 62.5 µl aliquots of the positive control compound, cyclophosphamide, at a final concentration of 20 µg/ml. The cultures were then incubated at 37°C. To the remaining set of cultures (i.e. without S-9 mix) 50 µl aliquots of the test compound were added giving final concentrations of 4, 20 and 40 µg/ml. 50 µl aliquots of the solvent were added to four cultures, and 50 µl aliquots mitomycin C, which was used as the positive control at a final concentration of 0.4 µg/ml, were added to two cultures. The cultures were then incubated at 37°C. Four hours after addition of test compound those cultures treated with S-9 mix had the medium carefully removed and replaced with fresh Hams F12 + 5% FC5. The cultures were then returned to the incubator for a further 17 hours.
All cultures were treated with colchicine, harvested, fixed and slides prepared as described in section {e}. The slides were stained in 10% Giemsa, mounted in DPX and coded. Metaphase spreads were identified using a magnification of x160 and examined at a magnification of x1000 using an oil immersion objective. Approximately 100 metaphase figures were examined where possible from each culture, with normally a maximum of 25 from each slide. - Remarks on result:
- other: strain/cell type: K1-BH4
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
It is concluded that ODB-2 has shown no evidence of clastogenic activity in this in vitro cytogenetic test system.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.